Ovarian Tumor Classification Guidelines

Introduction to IOTA Classification Systems

The IOTA guidelines provide a standardized, evidence-based ultrasound classification system using Simple Rules and the ADNEX model to differentiate benign from malignant adnexal masses, with the Simple Rules achieving 93% sensitivity and 95% specificity when applicable 1

The IOTA Simple Rules utilize 10 specific ultrasound features—5 benign (B features) and 5 malignant (M features)—to classify adnexal masses, including unilocular cyst, solid components <7 mm in height, acoustic shadows present, smooth multilocular tumor <100 mm diameter, and no detectable blood flow on color Doppler 2
The M features include irregular solid tumor, at least 4 papillary structures, irregular multilocular-solid tumor ≥100 mm diameter, and very strong blood flow on color Doppler 2

The ADNEX model is a mathematical algorithm that calculates specific probabilities for benign mass, borderline malignancy, Stage I primary invasive malignancy, Stage II-IV primary invasive malignancy, and metastasis to the ovary from another primary tumor 3, 1

The American College of Radiology's O-RADS incorporates IOTA terminology and was validated using the IOTA database of 5,905 surgically managed patients 3, 4
O-RADS provides six risk categories (0-5) with specific management recommendations, addressing the IOTA Simple Rules limitation by offering guidance for inconclusive cases and almost certainly benign lesions 3, 4

Color or power Doppler evaluation is essential when applying IOTA criteria, as it differentiates true solid components from debris and confirms vascularity patterns 2
Ensure complete Doppler assessment is performed, as absence of color flow is a benign feature while very strong flow suggests malignancy 2

The American College of Radiology (ACR) identifies ascites and pleural effusions as important imaging features in the evaluation of malignant adnexal masses, which are key characteristics of ovarian cancer 5, 6, 7
The International Ovarian Tumor Analysis (IOTA) Simple Rules for predicting malignancy in adnexal masses consider ascites as one of the five key malignant features (M features) that strongly suggest ovarian cancer 5, 6, 7, 8
Pleural effusion occurs in ovarian cancer through peritoneal-pleural communication and lymphatic obstruction, with the right hemithorax being most commonly affected 9
The adnexal mass location (right ovary/fallopian tube) directly correlates with the primary tumor site in ovarian malignancy 5, 6

Cervical cancer does not typically present with adnexal masses or pleural effusion as initial manifestations 5
Endometrial cancer rarely causes pleural effusion or significant ascites, and would not present with an adnexal mass as the primary finding 5
Uterine malignancies do not typically present with adnexal masses 5

The ACR guidelines emphasize that US imaging features including ascites, pleural effusions, and peritoneal/omental metastases are crucial for evaluating extent of disease in suspected ovarian malignancy 5, 6, 7

The American College of Radiology’s Ovarian‑Adnexal Reporting and Data System (O‑RADS) integrates International Endometrial Tumor Analysis (IETA) terminology to characterize adnexal masses, while IETA itself is dedicated to endometrial pathology. 10

O‑RADS was validated using the International Ovarian Tumor Analysis (IOTA) database and provides six risk categories (0–5) with specific management recommendations for adnexal lesions. 11